![Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives | Molecular Pharmaceutics Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.2c00007/asset/images/medium/mp2c00007_0017.gif)
Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives | Molecular Pharmaceutics
![Effect of Bile Acid Sequestrants on the Risk of Cardiovascular Events | Circulation: Cardiovascular Genetics Effect of Bile Acid Sequestrants on the Risk of Cardiovascular Events | Circulation: Cardiovascular Genetics](https://www.ahajournals.org/cms/asset/ce6f36fd-e4ca-4c6f-8189-722320667d12/618fig01.jpeg)
Effect of Bile Acid Sequestrants on the Risk of Cardiovascular Events | Circulation: Cardiovascular Genetics
![Microorganisms | Free Full-Text | Bile Salt Hydrolases: At the Crossroads of Microbiota and Human Health Microorganisms | Free Full-Text | Bile Salt Hydrolases: At the Crossroads of Microbiota and Human Health](https://pub.mdpi-res.com/microorganisms/microorganisms-09-01122/article_deploy/html/images/microorganisms-09-01122-g001.png?1621674772)
Microorganisms | Free Full-Text | Bile Salt Hydrolases: At the Crossroads of Microbiota and Human Health
![Frontiers | The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease Frontiers | The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease](https://www.frontiersin.org/files/Articles/908011/fmicb-13-908011-HTML/image_m/fmicb-13-908011-g001.jpg)
Frontiers | The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease
![2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution](https://www.jacc.org/cms/asset/fc511185-5e19-4d98-8444-30914b9ad0fe/gr7.jpg)
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution
![Relative variations of gut microbiota in disordered cholesterol metabolism caused by high‐cholesterol diet and host genetics - Bo - 2017 - MicrobiologyOpen - Wiley Online Library Relative variations of gut microbiota in disordered cholesterol metabolism caused by high‐cholesterol diet and host genetics - Bo - 2017 - MicrobiologyOpen - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/822f6035-186b-47e1-934a-b3309c9b63d4/mbo3491-fig-0004-m.jpg)
Relative variations of gut microbiota in disordered cholesterol metabolism caused by high‐cholesterol diet and host genetics - Bo - 2017 - MicrobiologyOpen - Wiley Online Library
![Molecules | Free Full-Text | The Bioavailability and Biological Activities of Phytosterols as Modulators of Cholesterol Metabolism Molecules | Free Full-Text | The Bioavailability and Biological Activities of Phytosterols as Modulators of Cholesterol Metabolism](https://www.mdpi.com/molecules/molecules-27-00523/article_deploy/html/images/molecules-27-00523-g004.png)
Molecules | Free Full-Text | The Bioavailability and Biological Activities of Phytosterols as Modulators of Cholesterol Metabolism
![Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics | Signal Transduction and Targeted Therapy Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-022-01125-5/MediaObjects/41392_2022_1125_Fig1_HTML.png)
Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics | Signal Transduction and Targeted Therapy
![2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task](https://www.jacc.org/cms/asset/d96bf82f-9139-4a26-8094-4e28ae0ef233/gr2b.jpg)
2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task
![Gut microbiome-mediated mechanisms for reducing cholesterol levels: implications for ameliorating cardiovascular disease: Trends in Microbiology Gut microbiome-mediated mechanisms for reducing cholesterol levels: implications for ameliorating cardiovascular disease: Trends in Microbiology](https://www.cell.com/cms/attachment/6d925b1e-e466-49b5-a940-45d459a172cc/gr1_lrg.jpg)